Kennedy's Next Move: New Policy on Pharmaceutical Advertising

U.S. health secretary Robert F. Kennedy Jr. announced during a Senate hearing that he plans to unveil a new policy on pharmaceutical advertising in the coming weeks, emphasizing his commitment to addressing this critical issue.

U.S. health secretary Robert F. Kennedy Jr. revealed plans to introduce a new pharmaceutical advertising policy soon.

Addressing a Senate Committee on Health, Education, Labor & Pensions, Kennedy emphasized the urgency of this issue, and the policy is expected in just a few weeks.

His statement highlights the administration's focus on regulating pharmaceutical advertisements to ensure public health accountability.